Last, TARGET-AML data from the Survival Genie website (https://bbisr.shinyapps.winship.emory.edu/SurvivalGenie/) revealed poor survival rates for patients with AML who had high NFATC3 expression levels (Figure 7A). The gene discussed is NFATC3; the disease is acute myeloid leukemia.